Cytori Therapeutics (CYTX) Misses Q4 EPS by 1c
Tweet Send to a FriendGet Alerts CYTX Hot Sheet
Price: $2.50 -2.72%
Revenue Growth %: +251.0%
Financial Fact:
Other income (expense), net: -173K
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: +251.0%
Financial Fact:
Other income (expense), net: -173K
Today's EPS Names:
ANF, DXLG, FL, More
Trade CYTX Now!
Cytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.38 million versus the consensus estimate of $2.01 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Hibbett Sports, Inc. (HIBB) Misses Q1 EPS by 7c; Maintains FY Outlook
- Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
